Page 15 - Export-Marketing-6

special status and direct relationship with
the life and health of mankind.
The high income of prominent
pharmaceutical companies in the world
has paved the way to spend a remarkable
part of their income on research and
development.
All over the world, pharmaceutical
companies spend 40% of their income
on research, development, marketing,
and sales.
Researches show that sometimes a
15-year period is needed for research on
nearly 10,000 medicinal mixtures with a
cost of one billion dollars.
The pharmaceutical industry is seriously
monopolized. Most of these products
are made in North America and Europe.
Statistics show that North America had
the highest share of the global market in
2013 while Africa and West Asia had just
4% of the share.
The pharmaceutical market is measured
by the turnover of the medical industry.

This turnover includes the sale of basic
materials, the sale of medicines to
consumers, the import and export of
medicines, the volume of investments,
and the value of pharmaceutical
companies.
As in the global pharmaceutical market,
the so-called developed countries are
pioneers in producing and consuming
these medicines and possess about 79%
of the whole market. In other words, the